FeaturedNeurosciencePsychology·June 3, 2026·8 min readAre Long-Term Antidepressant Benefits Overstated?A new study reveals a lack of robust evidence proving that antidepressants prevent relapse beyond 12 months.Read More
FeaturedNeurosciencePsychology·May 20, 2026·12 min readArthritis Drug Rescues Hard-to-Treat DepressionThe anti-inflammatory drug tocilizumab can successfully induce remission in patients struggling with treatment-resistant depression.Read More
FeaturedNeurosciencePsychology·May 19, 2026·16 min readBuprenorphin and Ketamine Combo Provide Anti-Suicidal EffectA sequential combination of a single ketamine infusion followed by four weeks of low-dose daily buprenorphine successfully extends the antisuicidal window of ketamine from one fleeting week to over a month.Read More
FeaturedNeurosciencePsychology·May 15, 2026·10 min readSingle Psilocybin Dose Sparks Rapid Depression RemissionCan a single dose of psilocybin replace daily antidepressants? A new randomized clinical trial shows that a 25 mg dose of the psychedelic compound delivers rapid, clinically meaningful symptom reductions for common depression in just 48 hours.Read More
FeaturedNeurosciencePsychologyVisual Neuroscience·May 14, 2026·6 min readBrain-Stimulating Contact Lenses Match Prozac in Depression StudyResearchers have created transparent, flexible contact lenses that treat depression using "temporal interference" electrical stimulation. In a landmark study, the lenses restored brain connectivity and boosted serotonin by 47%, matching the performance of leading antidepressants.Read More
FeaturedNeurosciencePsychology·May 7, 2026·9 min readPsilocybin Rebuilds the Brain’s Physical WiringNew research from UCSF shows that a single high dose of the psychedelic compound creates lasting anatomical changes in brain tracts and "loosens" rigid thought patterns, leading to significant improvements in psychological insight and well-being that persist for over a month.Read More
FeaturedNeuroscienceOpen Neuroscience ArticlesPsychology·May 7, 2026·8 min readPsilocybin Dampens Aggression and Attack BehaviorsNew research shows that low doses of the psychoactive compound can reduce high-energy aggressive behaviors in mangrove rivulus fish while keeping social communication intact, offering a new vertebrate model for studying the drug's impact on social conflict.Read More
FeaturedNeurosciencePsychology·May 1, 2026·11 min readHow Scientists Cracked the Ketamine Code for DepressionBy "reverse engineering" ketamine, Weill Cornell investigators have identified a specific opioid receptor pathway and a unique receptor "cross-talk" that drives rapid antidepressant effects.Read More
Auditory NeuroscienceFeaturedNeurosciencePsychology·April 20, 2026·7 min readSSRIs May Trigger TinnitusA new study identifies a specific serotonin circuit that triggers the auditory system, explaining why SSRIs can worsen tinnitus and offering a new target for treatment.Read More
FeaturedNeurosciencePsychology·April 8, 2026·8 min readHow Science Solved the Mystery of the Psychedelic HighA massive international study identifies a universal pattern of brain activity across psilocybin, LSD, DMT, and more. Researchers found that all major psychedelics dissolve brain network boundaries, triggering global "cross-talk."Read More
FeaturedNeurosciencePsychology·March 30, 2026·8 min readBlocking NOX-1 Extends Ketamine’s Effectiveness for DepressionResearchers have identified the NOX-1 enzyme as the reason ketamine's antidepressant effects are short-lived. By blocking NOX-1, they extended the drug's benefits from days to weeks.Read More
FeaturedNeurosciencePsychology·March 25, 2026·8 min readADHD Medication May Shield Against PsychosisA massive study of 700,000 people shows that ADHD medication in childhood does not increase the risk of psychosis. In fact, starting treatment before age 13 may help protect against schizophrenia in adulthood.Read More
